Extracellular Matrix/Glycopeptide Hybrid Hydrogel as an Immunomodulatory Niche for Endogenous Cardiac Repair after Myocardial Infarction
Advanced Science · 2023
DOI: 10.1002/advs.202301244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Pengxu Kong und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Structural Heart Disease, National Center for Cardiovascular Disease, China and State Key Laboratory of Cardiovascular Disease, Fuwai H…. Hauptthemen laut MEDLINE: Hydrogels, Myocardial Infarction. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
The treatment of myocardial infarction (MI) remains a substantial challenge due to excessive inflammation, massive cell death, and restricted regenerative potential, leading to maladaptive healing process and eventually heart failure. Current strategies of regulating inflammation or improving cardiac tissue regeneration have limited success. Herein, a hybrid hydrogel coassembled by acellular cardiac extracellular matrix (ECM) and immunomodulatory glycopeptide is developed for endogenous tissue regeneration after MI. The hydrogel constructs a niche recapitulating the architecture of native ECM for attracting host cell homing, controlling macrophage differentiation via glycopeptide unit, and promoting endotheliocyte proliferation by enhancing the macrophage‐endotheliocyte crosstalk, which coordinate the innate healing mechanism for cardiac tissue regeneration. In a rodent MI model, the hybrid hydrogel successfully orchestrates a proreparative response indicated by enhanced M2 macrophage polarization, increased angiogenesis, and improved cardiomyocyte survival, which alleviates infarct size, improves wall thicknesses, and enhances cardiac contractility. Furthermore, the safety and effectiveness of the hydrogel are demonstrated in a porcine MI model, wherein proteomics verifies the regulation of immune response, proangiogenesis, and accelerated healing process. Collectively, the injectable composite hydrogel serving as an immunomodulatory niche for promoting cell homing and proliferation, inflammation modulation, tissue remodeling, and function restoration provides an effective strategy for endogenous cardiac repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Structural Heart Disease, National Center for Cardiovascular Disease, China and State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical…
- Department of Pediatric Cardiac Surgery, Huazhong Fuwai Hospital, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, 450000, China.
- Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300192, China.
- Department of Polymer Science and Engineering, Key Laboratory of Systems Bioengineering (Ministry of Education), School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, China.
- Department of Cardiac Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.
- Key Laboratory of Innovative Cardiovascular Devices, Chinese Academy of Medical Sciences, Beijing, 100037, China.
ORCID-Profile: Xiangbin Pan
Förderung
- CAMS Innovation Fund for Medical Sciences
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Beijing Municipal Science and Technology Project
- National high level talents special support plan
- Sanming Project of Medicine in Shenzhen
- Natural Science Fund for Distinguished Young Scholars of Tianjin
Zitieren
APA
Kong, P., Dong, J., Li, W., Li, Z., Gao, R., Liu, X., Wang, J., Su, Q., Wen, B., Ouyang, W., Wang, S., Zhang, F., Feng, S., Zhuang, D., Xie, Y., Zhao, G., Yi, H., Feng, Z., Wang, W., & Pan, X. (2023). Extracellular Matrix/Glycopeptide Hybrid Hydrogel as an Immunomodulatory Niche for Endogenous Cardiac Repair after Myocardial Infarction. Advanced Science. https://doi.org/10.1002/advs.202301244
Vancouver
Kong P, Dong J, Li W, Li Z, Gao R, Liu X, et al. Extracellular Matrix/Glycopeptide Hybrid Hydrogel as an Immunomodulatory Niche for Endogenous Cardiac Repair after Myocardial Infarction. Advanced Science. 2023. doi:10.1002/advs.202301244
BibTeX
@article{Kong2023,
author = {Kong, Pengxu and Dong, Jing and Li, Wenchao and Li, Zefu and Gao, Rui and Liu, Xiang and Wang, Jingrong and Su, Qi and Wen, Bin and Ouyang, Wenbin and Wang, Shouzheng and Zhang, Fengwen and Feng, Shuyi and Zhuang, Donglin and Xie, Yongquan and Zhao, Guangzhi and Yi, Hang and Feng, Zujian and Wang, Weiwei and Pan, Xiangbin},
title = {Extracellular Matrix/Glycopeptide Hybrid Hydrogel as an Immunomodulatory Niche for Endogenous Cardiac Repair after Myocardial Infarction},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202301244}
}
EUVIMED